SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
BETHLEHEM, Pa., Oct. 25, 2017 -- B. Braun Medical Inc., a market leader in regional anesthesia, has epidural and spinal anesthesia products with NRFit™ connectors available for sale in compliance with International Organization for Standardization (ISO) 80369-6 and California State Legislation.
ISO standards for small bore connectors are intended to help prevent misconnections and improve patient safety. In accordance with ISO standards, all healthcare facilities are expected to transition to products that meet this standard for neuraxial and regional anesthesia. Additionally, California took legislative action to mandate that healthcare facilities transition to non-luer epidural products at the start of this year.
The current design of universal luer connectors poses the risk of inadvertent misconnections. The new NRFit connector design helps to avoid connections between medical devices meant for neuraxial administration and devices used for IV, enteral and other applications. By using devices with NRFit connectors, clinicians can help reduce the risk of misconnection between applications and help reduce medical errors.
“B. Braun has been at the forefront of preparing for this change,” said Peter McGregor, Director of Marketing, Pain Control at B. Braun. “We have taken an active role in helping our customers comply with the evolving industry safety standards, including transitioning to products with NRFit connectors. As a leader in regional anesthesia products and a strong advocate for patient safety, B. Braun is committed to providing the safest delivery of medications in healthcare settings to help improve patient outcomes.”
For more information, visit www.BBraunNRFit.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]
